Citations

Citations to this article as recorded by  

• Effects of a DPP-4 Inhibitor and RAS Blockade on Clinical Outcomes of Patients with Diabetes and COVID-19
  Sang Youl Rhee, Jeongwoo Lee, Hyewon Nam, Dae-Sung Kyoung, Dong Wook Shin, Dae Jung Kim
  Diabetes & Metabolism Journal.2021; 45(2): 251.     CrossRef
• Dissection of non-pharmaceutical interventions implemented by Iran, South Korea, and Turkey in the fight against COVID-19 pandemic
  Mohammad Keykhaei, Sogol Koolaji, Esmaeil Mohammadi, Reyhaneh Kalantar, Sahar Saeedi Moghaddam, Arya Aminorroaya, Shaghayegh Zokaei, Sina Azadnajafabad, Negar Rezaei, Erfan Ghasemi, Nazila Rezaei, Rosa Haghshenas, Yosef Farzi, Sina Rashedi, Bagher Larijan
  Journal of Diabetes & Metabolic Disorders.2021; 20(2): 1919.     CrossRef
• Diabetes and COVID-19: Global and regional perspectives
  In-Kyung Jeong, Kun Ho Yoon, Moon Kyu Lee
  Diabetes Research and Clinical Practice.2020; 166: 108303.     CrossRef

Fibrates, peroxisome proliferator-activated receptor-α agonists, are potent lipid-modifying drugs. Their main effects are reduction of triglycerides and increase in high-density lipoprotein levels. Several randomized controlled trials have not demonstrated their benefits on cardiovascular risk reduction, especially as an “add on” to statin therapy. However, subsequent analyses by major clinical trials, meta-analyses, and real-world evidence have proposed their potential in specific patient populations with atherogenic dyslipidemia and metabolic syndrome. Here, we have reviewed and discussed the accumulated data on fibrates to understand their current status in cardiovascular risk management.

Citations

Citations to this article as recorded by  

• Associations of omega-3 fatty acids vs. fenofibrate with adverse cardiovascular outcomes in people with metabolic syndrome: propensity matched cohort study
  Nam Hoon Kim, Ji Yoon Kim, Jimi Choi, Sin Gon Kim
  European Heart Journal - Cardiovascular Pharmacotherapy.2024; 10(2): 118.     CrossRef
• Role of PPARα in inflammatory response of C2C12 myotubes
  Yuki Shimizu, Keiko Hamada, Tingting Guo, Chie Hasegawa, Yusuke Kuga, Katsushi Takeda, Takashi Yagi, Hiroyuki Koyama, Hiroshi Takagi, Daisuke Aotani, Hiromi Kataoka, Tomohiro Tanaka
  Biochemical and Biophysical Research Communications.2024; 694: 149413.     CrossRef
• Obicetrapib: Reversing the Tide of CETP Inhibitor Disappointments
  John J. P. Kastelein, Andrew Hsieh, Mary R. Dicklin, Marc Ditmarsch, Michael H. Davidson
  Current Atherosclerosis Reports.2024; 26(2): 35.     CrossRef
• Metabolic Flexibility of the Heart: The Role of Fatty Acid Metabolism in Health, Heart Failure, and Cardiometabolic Diseases
  Virginia Actis Dato, Stephan Lange, Yoshitake Cho
  International Journal of Molecular Sciences.2024; 25(2): 1211.     CrossRef
• ApoB100 and Atherosclerosis: What’s New in the 21st Century?
  Dimitris Kounatidis, Natalia G. Vallianou, Aikaterini Poulaki, Angelos Evangelopoulos, Fotis Panagopoulos, Theodora Stratigou, Eleni Geladari, Irene Karampela, Maria Dalamaga
  Metabolites.2024; 14(2): 123.     CrossRef
• Follistatin-like 1 (FSTL1) levels as potential early biomarker of cardiovascular disease in a Mexican population
  N. Ponce-Ruíz, J. F. Herrera-Moreno, A. E. Rojas-García, B. S. Barrón-Vivanco, C. A. González-Arias, Y. Y. Bernal-Hernández, L. Ortega-Cervantes, J. Ponce-Gallegos, J. A. Hernández-Nolasco, I. M. Medina-Díaz
  Heart and Vessels.2024; 39(6): 563.     CrossRef
• Role of Fenofibrate Use in Dyslipidemia and Related Comorbidities in the Asian Population: A Narrative Review
  Chaicharn Deerochanawong, Sin Gon Kim, Yu-Cheng Chang
  Diabetes & Metabolism Journal.2024; 48(2): 184.     CrossRef
• Coenzyme Q10 in atherosclerosis
  Minjun Liao, Xueke He, Yangyang Zhou, Weiqiang Peng, Xiao-Mei Zhao, Miao Jiang
  European Journal of Pharmacology.2024; 970: 176481.     CrossRef
• Onion Polyphenols as Multi-Target-Directed Ligands in MASLD: A Preliminary Molecular Docking Study
  Maria Rosaria Paravati, Anna Caterina Procopio, Maja Milanović, Giuseppe Guido Maria Scarlata, Nataša Milošević, Maja Ružić, Nataša Milić, Ludovico Abenavoli
  Nutrients.2024; 16(8): 1226.     CrossRef
• Therapeutic approach in the treatment of dyslipidemia: Novelties and challenges
  Katarina Lalić, Nataša Rajković, Ljiljana Popović, Sandra Singh-Lukač, Iva Rasulić, Ana Petakov, Milica Krstić, Marija Mitrović
  Galenika Medical Journal.2024; 3(9): 31.     CrossRef
• Research trends in lipid-lowering therapies for coronary heart disease combined with hyperlipidemia: a bibliometric study and visual analysis
  Quankai Cheng, Jingjing Sun, Haicheng Zhong, Ziming Wang, Chang Liu, Sheng Zhou, Jie Deng
  Frontiers in Pharmacology.2024;[Epub]     CrossRef
• Expression of FAM159B in Humans, Rats, and Mice: A Cross-species Examination
  Anna-Sophia Liselott Beyer, Daniel Kaemmerer, Jörg Sänger, Amelie Lupp
  Journal of Histochemistry & Cytochemistry.2024; 72(7): 467.     CrossRef
• The Pleiotropic Effects of Lipid-Modifying Interventions: Exploring Traditional and Emerging Hypolipidemic Therapies
  Dimitris Kounatidis, Nikolaos Tentolouris, Natalia G. Vallianou, Iordanis Mourouzis, Irene Karampela, Theodora Stratigou, Eleni Rebelos, Marina Kouveletsou, Vasileios Stamatopoulos, Eleni Tsaroucha, Maria Dalamaga
  Metabolites.2024; 14(7): 388.     CrossRef
• Fenofibrate’s impact on cardiovascular risk in patients with diabetes: a nationwide propensity-score matched cohort study
  Sangmo Hong, Kyung-Soo Kim, Kyungdo Han, Cheol-Young Park
  Cardiovascular Diabetology.2024;[Epub]     CrossRef
• The role of DGAT1 and DGAT2 in tumor progression via fatty acid metabolism: A comprehensive review
  Leisheng Wang, Shiwei Xu, Mengzhen Zhou, Hao Hu, Jinyou Li
  International Journal of Biological Macromolecules.2024; 278: 134835.     CrossRef
• Study Design and Protocol for a Randomized Controlled Trial to Assess Long-Term Efficacy and Safety of a Triple Combination of Ezetimibe, Fenofibrate, and Moderate-Intensity Statin in Patients with Type 2 Diabetes and Modifiable Cardiovascular Risk Factor
  Nam Hoon Kim, Juneyoung Lee, Suk Chon, Jae Myung Yu, In-Kyung Jeong, Soo Lim, Won Jun Kim, Keeho Song, Ho Chan Cho, Hea Min Yu, Kyoung-Ah Kim, Sang Soo Kim, Soon Hee Lee, Chong Hwa Kim, Soo Heon Kwak, Yong‐ho Lee, Choon Hee Chung, Sihoon Lee, Heung Yong J
  Endocrinology and Metabolism.2024; 39(5): 722.     CrossRef
• Safety and Efficacy of the Novel RNA Interference Therapies for Hypertriglyceridemia and Mixed Hyperlipidemia Management: A Systematic Review and Meta-analysis
  A.B.M. Kamrul-Hasan, Deep Dutta, Lakshmi Nagendra, Sunetra Mondal, Saptarshi Bhattacharya, Sanjay Kalra
  Endocrine Practice.2024; 30(11): 1103.     CrossRef
• Effects of Fatty Acid Metabolism on Heart Failure
  日娜 萨
  Advances in Clinical Medicine.2024; 14(09): 787.     CrossRef
• Revisiting PPAR agonists: novel perspectives in the treatment of primary biliary cholangitis
  Yiran Chen, Kunyu Zheng, Gahu Da, Xu Wang, Yi Wei, Guochun Wang, Fengchun Zhang, Li Wang
  Expert Opinion on Pharmacotherapy.2024; 25(13): 1825.     CrossRef
• Integrated review of cardiometabolic biomarkers and dietary nutrients
  Ravindra Verma, Prakash S Bisen, Mònica Bulló
  Journal of Food Bioactives.2024; : 44.     CrossRef
• Cardiovascular Diseases and Metabolic Medications in the Lebanese Population: A Post Hoc Analysis from a Nationwide Cross-Sectional Study
  Rony M. Zeenny, Rachel Abdo, Chadia Haddad, Aline Hajj, Rouba Karen Zeidan, Pascale Salameh, Jean Ferrieres
  Pharmacy.2024; 12(6): 171.     CrossRef
• Present and Future of Dyslipidaemia Treatment—A Review
  Iveta Merćep, Andro Vujević, Dominik Strikić, Ivana Radman, Ivan Pećin, Željko Reiner
  Journal of Clinical Medicine.2023; 12(18): 5839.     CrossRef
• VLDL receptor gene therapy for reducing atherogenic lipoproteins
  Ronald M. Krauss, Jonathan T. Lu, Joseph J. Higgins, Cathryn M. Clary, Ray Tabibiazar
  Molecular Metabolism.2023; 69: 101685.     CrossRef
• The emerging role of PPAR-alpha in breast cancer
  Zhiwen Qian, Lingyan Chen, Jiayu Liu, Ying Jiang, Yan Zhang
  Biomedicine & Pharmacotherapy.2023; 161: 114420.     CrossRef
• Molecular mechanisms and therapeutic perspectives of peroxisome proliferator‐activated receptor α agonists in cardiovascular health and disease
  Yujie Pu, Chak Kwong Cheng, Hongsong Zhang, Jiang‐Yun Luo, Li Wang, Brian Tomlinson, Yu Huang
  Medicinal Research Reviews.2023; 43(6): 2086.     CrossRef
• Macrophage angiotensin-converting enzyme reduces atherosclerosis by increasing peroxisome proliferator-activated receptor α and fundamentally changing lipid metabolism
  DuoYao Cao, Zakir Khan, Xiaomo Li, Suguru Saito, Ellen A Bernstein, Aaron R Victor, Faizan Ahmed, Aoi O Hoshi, Luciana C Veiras, Tomohiro Shibata, Mingtian Che, Lei Cai, Michifumi Yamashita, Ryan E Temel, Jorge F Giani, Daniel J Luthringer, Ajit S Divakar
  Cardiovascular Research.2023; 119(9): 1825.     CrossRef
• Rapid flow synthesis of fenofibrate via scalable flash chemistry with in-line Li recovery
  Sanket A. Kawale, Dong-Chang Kang, Gwang-Noh Ahn, Amirreza Mottafegh, Ji-Ho Kang, Gi-Su Na, Dong-Pyo Kim
  Chemical Engineering Journal.2023; 477: 147033.     CrossRef
• Effectiveness and Safety of Fenofibrate in Routine Treatment of Patients with Hypertriglyceridemia and Metabolic Syndrome
  Marat V. Ezhov, Gregory P. Arutyunov
  Diseases.2023; 11(4): 140.     CrossRef
• Development of New Genome Editing Tools for the Treatment of Hyperlipidemia
  Giulio Preta
  Cells.2023; 12(20): 2466.     CrossRef
• Exploring the hypolipidemic effects of bergenin from Saxifraga melanocentra Franch: mechanistic insights and potential for hyperlipidemia treatment
  Li Zhang, Yingying Tong, Yan Fang, Jinjin Pei, Qilan Wang, Gang Li
  Lipids in Health and Disease.2023;[Epub]     CrossRef
• Obesity and Dyslipidemia
  Barbora Nussbaumerova, Hana Rosolova
  Current Atherosclerosis Reports.2023; 25(12): 947.     CrossRef
• Bibliometric analysis of residual cardiovascular risk: trends and frontiers
  Lin Wang, Sutong Wang, Chaoyuan Song, Yiding Yu, Yuehua Jiang, Yongcheng Wang, Xiao Li
  Journal of Health, Population and Nutrition.2023;[Epub]     CrossRef
• Hypertriglyceridemia in Apoa5–/– mice results from reduced amounts of lipoprotein lipase in the capillary lumen
  Ye Yang, Anne P. Beigneux, Wenxin Song, Le Phuong Nguyen, Hyesoo Jung, Yiping Tu, Thomas A. Weston, Caitlyn M. Tran, Katherine Xie, Rachel G. Yu, Anh P. Tran, Kazuya Miyashita, Katsuyuki Nakajima, Masami Murakami, Yan Q. Chen, Eugene Y. Zhen, Joonyoung R.
  Journal of Clinical Investigation.2023;[Epub]     CrossRef
• Blood-Derived Lipid and Metabolite Biomarkers in Cardiovascular Research from Clinical Studies: A Recent Update
  Dipali Kale, Amol Fatangare, Prasad Phapale, Albert Sickmann
  Cells.2023; 12(24): 2796.     CrossRef
• Effective, disease-modifying, clinical approaches to patients with mild-to-moderate hypertriglyceridaemia
  Gary F Lewis, Robert A Hegele
  The Lancet Diabetes & Endocrinology.2022; 10(2): 142.     CrossRef
• Effects of Alirocumab on Triglyceride Metabolism: A Fat-Tolerance Test and Nuclear Magnetic Resonance Spectroscopy Study
  Thomas Metzner, Deborah R. Leitner, Karin Mellitzer, Andrea Beck, Harald Sourij, Tatjana Stojakovic, Gernot Reishofer, Winfried März, Ulf Landmesser, Hubert Scharnagl, Hermann Toplak, Günther Silbernagel
  Biomedicines.2022; 10(1): 193.     CrossRef
• Is there a role of lipid-lowering therapies in the management of fatty liver disease?
  Ismini Tzanaki, Aris P Agouridis, Michael S Kostapanos
  World Journal of Hepatology.2022; 14(1): 119.     CrossRef
• Therapeutic Strategies and Chemoprevention of Atherosclerosis: What Do We Know and Where Do We Go?
  Ana Clara Aprotosoaie, Alexandru-Dan Costache, Irina-Iuliana Costache
  Pharmaceutics.2022; 14(4): 722.     CrossRef
• The Overlooked Transformation Mechanisms of VLCFAs: Peroxisomal β-Oxidation
  Qinyue Lu, Weicheng Zong, Mingyixing Zhang, Zhi Chen, Zhangping Yang
  Agriculture.2022; 12(7): 947.     CrossRef
• Current Trends of Big Data Research Using the Korean National Health Information Database
  Mee Kyoung Kim, Kyungdo Han, Seung-Hwan Lee
  Diabetes & Metabolism Journal.2022; 46(4): 552.     CrossRef
• New, Novel Lipid-Lowering Agents for Reducing Cardiovascular Risk: Beyond Statins
  Kyuho Kim, Henry N. Ginsberg, Sung Hee Choi
  Diabetes & Metabolism Journal.2022; 46(4): 517.     CrossRef
• Novel Targets for a Combination of Mechanical Unloading with Pharmacotherapy in Advanced Heart Failure
  Agata Jedrzejewska, Alicja Braczko, Ada Kawecka, Marcin Hellmann, Piotr Siondalski, Ewa Slominska, Barbara Kutryb-Zajac, Magdi H. Yacoub, Ryszard T. Smolenski
  International Journal of Molecular Sciences.2022; 23(17): 9886.     CrossRef
• Lipoprotein Lipase: Is It a Magic Target for the Treatment of Hypertriglyceridemia
  Joon Ho Moon, Kyuho Kim, Sung Hee Choi
  Endocrinology and Metabolism.2022; 37(4): 575.     CrossRef
• Fenofibrate add-on to statin treatment is associated with low all-cause death and cardiovascular disease in the general population with high triglyceride levels
  Kyung-Soo Kim, Sangmo Hong, Kyungdo Han, Cheol-Young Park
  Metabolism.2022; 137: 155327.     CrossRef
• Alterations of HDL’s to piHDL’s Proteome in Patients with Chronic Inflammatory Diseases, and HDL-Targeted Therapies
  Veronika Vyletelová, Mária Nováková, Ľudmila Pašková
  Pharmaceuticals.2022; 15(10): 1278.     CrossRef
• Cardiovascular Risk Profile and Lipid Management in the Population-Based Cohort Study LATINO: 20 Years of Real-World Data
  Cristina Gavina, Daniel Seabra Carvalho, Marisa Pardal, Marta Afonso-Silva, Diana Grangeia, Ricardo Jorge Dinis-Oliveira, Francisco Araújo, Tiago Taveira-Gomes
  Journal of Clinical Medicine.2022; 11(22): 6825.     CrossRef
• New and Emerging lipid-lowering Therapy
  James M Backes, Daniel E Hilleman
  Future Cardiology.2021; 17(8): 1407.     CrossRef
• Systemic PFOS and PFOA exposure and disturbed lipid homeostasis in humans: what do we know and what not?
  Styliani Fragki, Hubert Dirven, Tony Fletcher, Bettina Grasl-Kraupp, Kristine Bjerve Gützkow, Ron Hoogenboom, Sander Kersten, Birgitte Lindeman, Jochem Louisse, Ad Peijnenburg, Aldert H. Piersma, Hans M. G. Princen, Maria Uhl, Joost Westerhout, Marco J. Z
  Critical Reviews in Toxicology.2021; 51(2): 141.     CrossRef
• A network pharmacology analysis on drug‐like compounds from Ganoderma lucidum for alleviation of atherosclerosis
  Ki Kwang Oh, Md. Adnan, Dong Ha Cho
  Journal of Food Biochemistry.2021;[Epub]     CrossRef
• Efficacy and Safety of Fenofibrate-Statin Combination Therapy in Patients With Inadequately Controlled Triglyceride Levels Despite Previous Statin Monotherapy: A Multicenter, Randomized, Double-blind, Phase IV Study
  Myung Soo Park, Jong-Chan Youn, Eung Ju Kim, Ki Hoon Han, Sang Hak Lee, Sung Hea Kim, Byung Jin Kim, Sung Uk Kwon, Kyu-Hyung Ryu
  Clinical Therapeutics.2021; 43(10): 1735.     CrossRef
• Prevalence of and Factors Associated With the Prescription of Fibrates Among Patients Receiving Lipid-Lowering Drugs in Germany
  Louis Jacob, Roger-Axel Greiner, Mark Luedde, Karel Kostev
  Journal of Cardiovascular Pharmacology.2021; 78(6): 885.     CrossRef
• Challenging Issues in the Management of Cardiovascular Risk Factors in Diabetes During the COVID-19 Pandemic: A Review of Current Literature
  Leili Rahimi, Mojtaba Malek, Faramarz Ismail-Beigi, Mohammad E. Khamseh
  Advances in Therapy.2020; 37(8): 3450.     CrossRef
• Treatment With Gemfibrozil Prevents the Progression of Chronic Kidney Disease in Obese Dahl Salt-Sensitive Rats
  Corbin A. Shields, Bibek Poudel, Kasi C. McPherson, Andrea K. Brown, Ubong S. Ekperikpe, Evan Browning, Lamari Sutton, Denise C. Cornelius, Jan M. Williams
  Frontiers in Physiology.2020;[Epub]     CrossRef
• Oxidative Stress and Inflammation in Renal and Cardiovascular Complications of Diabetes
  Amelia Charlton, Jessica Garzarella, Karin A. M. Jandeleit-Dahm, Jay C. Jha
  Biology.2020; 10(1): 18.     CrossRef

Impaired β-cell function is the key pathophysiology of type 2 diabetes mellitus, and chronic exposure of nutrient excess could lead to this tragedy. For preserving β-cell function, it is essential to understand the cause and mechanisms about the progression of β-cells failure. Glucotoxicity, lipotoxicity, and glucolipotoxicity have been suggested to be a major cause of β-cell dysfunction for decades, but not yet fully understood. Fatty acid translocase cluster determinant 36 (CD36), which is part of the free fatty acid (FFA) transporter system, has been identified in several tissues such as muscle, liver, and insulin-producing cells. Several studies have reported that induction of CD36 increases uptake of FFA in several cells, suggesting the functional interplay between glucose and FFA in terms of insulin secretion and oxidative metabolism. However, we do not currently know the regulating mechanism and physiological role of CD36 on glucolipotoxicity in pancreatic β-cells. Also, the downstream and upstream targets of CD36 related signaling have not been defined. In the present review, we will focus on the expression and function of CD36 related signaling in the pancreatic β-cells in response to hyperglycemia and hyperlipidemia (ceramide) along with the clinical studies on the association between CD36 and metabolic disorders.

Citations

Citations to this article as recorded by  

• Nrf2 inhibition regulates intracellular lipid accumulation in mouse insulinoma cells and improves insulin secretory function
  Alpana Mukhuty, Samanwita Mandal, Chandrani Fouzder, Snehasis Das, Dipanjan Chattopadhyay, Tanmay Majumdar, Rakesh Kundu
  Molecular and Cellular Endocrinology.2024; 581: 112112.     CrossRef
• CD36 gene variant rs1761667(G/A) as a biomarker in obese type 2 diabetes mellitus cases
  Ashwin Kumar Shukla, Amreen Shamsad, Atar Singh Kushwah, Shalini Singh, Kauser Usman, Monisha Banerjee
  Egyptian Journal of Medical Human Genetics.2024;[Epub]     CrossRef
• CD36 regulates macrophage and endothelial cell activation and multinucleate giant cell formation in anti neutrophil cytoplasm antibody vasculitis
  Xiang Zhang, Catherine King, Alexander Dowell, Paul Moss, Lorraine Harper, Dimitrios Chanouzas, Xiong-zhong Ruan, Alan David Salama
  Clinical Immunology.2024; 260: 109914.     CrossRef
• Identification and validation of oxidative stress-related genes in sepsis-induced myopathy
  Ning Zhang, Dan Huang, Xiang Li, JinXia Yan, Qi Yan, WeiXing Ge, Jun Zhou
  Medicine.2024; 103(18): e37933.     CrossRef
• Monocyte CD36 Expression Predicts Disease Activity in Patients With Crohn’s Disease
  Jiejie Zhu, Nannan Zhu, Jiren Wang, Qiuyuan Liu, Qiao Mei, Andrew S. Day
  Gastroenterology Research and Practice.2024;[Epub]     CrossRef
• CD36 inhibition corrects lipid-FetuinA mediated insulin secretory defects by preventing intracellular lipid accumulation and inflammation in the pancreatic beta cells
  Samanwita Mandal, Snehasish Nag, Oindrila Mukherjee, Nandita Das, Priyajit Banerjee, Tanmay Majumdar, Satinath Mukhopadhyay, Kathrin Maedler, Rakesh Kundu
  Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2024; : 167580.     CrossRef
• The association of soluble cluster of differentiation 36 with metabolic diseases: A potential biomarker and therapeutic target
  Yun Li, Yaxi Chen, Xiong Z. Ruan
  Pediatric Discovery.2023;[Epub]     CrossRef
• The role of candidate transport proteins in β‐cell long‐chain fatty acid uptake: Where are we now?
  Christina Clavelo‐Farrow, Patricia Thomas
  Diabetic Medicine.2023;[Epub]     CrossRef
• SARS-CoV-2 in the pancreas and the impaired islet function in COVID-19 patients
  Ningfei Ji, Mingshun Zhang, Liang Ren, Yunyun Wang, Bicheng Hu, Jie Xiang, Yingyun Gong, Chaojie Wu, Guoqiang Qu, Wenqiu Ding, Zhiqiang Yin, Shan Li, Zhengxia Wang, Lianzheng Zhou, Xueqin Chen, Yuan Ma, Jinhai Tang, Yun Liu, Liang Liu, Mao Huang
  Emerging Microbes & Infections.2022; 11(1): 1115.     CrossRef
• Is imaging-based muscle quantity associated with risk of diabetes? A meta-analysis of cohort studies
  Shanhu Qiu, Xue Cai, Yang Yuan, Bo Xie, Zilin Sun, Tongzhi Wu
  Diabetes Research and Clinical Practice.2022; 189: 109939.     CrossRef
• Lipotoxicity in a Vicious Cycle of Pancreatic Beta Cell Exhaustion
  Vladimir Grubelnik, Jan Zmazek, Matej Završnik, Marko Marhl
  Biomedicines.2022; 10(7): 1627.     CrossRef
• Association of cluster determinant 36, scavenger receptor class B type 1, and major facilitator superfamily domain containing the 2a genetic polymorphism with serum lipid profile in aging population with type 2 diabetes mellitus
  Xixiang Wang, Xiaojun Ma, Jingjing Xu, Yujie Guo, Shaobo Zhou, Huiyan Yu, Linhong Yuan
  Frontiers in Nutrition.2022;[Epub]     CrossRef
• CD36-Fatty Acid-Mediated Metastasis via the Bidirectional Interactions of Cancer Cells and Macrophages
  Noorzaileen Eileena Zaidi, Nur Aima Hafiza Shazali, Thean-Chor Leow, Mohd Azuraidi Osman, Kamariah Ibrahim, Wan-Hee Cheng, Kok-Song Lai, Nik Mohd Afizan Nik Abd Rahman
  Cells.2022; 11(22): 3556.     CrossRef
• The Past and Present Lives of the Intraocular Transmembrane Protein CD36
  Rucui Yang, Qingping Liu, Mingzhi Zhang
  Cells.2022; 12(1): 171.     CrossRef
• Implicating the effect of ketogenic diet as a preventive measure to obesity and diabetes mellitus
  Sachin Kumar, Tapan Behl, Monika Sachdeva, Aayush Sehgal, Shilpa Kumari, Arun Kumar, Gagandeep Kaur, Harlokesh Narayan Yadav, Simona Bungau
  Life Sciences.2021; 264: 118661.     CrossRef
• Contribution of rs3211938 polymorphism at CD36 to glucose levels, oxidized low-density lipoproteins, insulin resistance, and body mass index in Mexican mestizos with type-2 diabetes from western Mexico
  Beatriz Teresita Martín-Márquez, Flavio Sandoval-Garcia, Mónica Vazquez-Del Mercado, Erika-Aurora Martínez-García, Fernanda-Isadora Corona-Meraz, Ana-Lilia Fletes-Rayas, Soraya-Amalí Zavaleta-Muñiz
  Nutrición Hospitalaria.2021;[Epub]     CrossRef
• Investigating the association of CD36 gene polymorphisms (rs1761667 and rs1527483) with T2DM and dyslipidemia: Statistical analysis, machine learning based prediction, and meta-analysis
  Ma’mon M. Hatmal, Walhan Alshaer, Ismail S. Mahmoud, Mohammad A. I. Al-Hatamleh, Hamzeh J. Al-Ameer, Omar Abuyaman, Malek Zihlif, Rohimah Mohamud, Mais Darras, Mohammad Al Shhab, Rand Abu-Raideh, Hilweh Ismail, Ali Al-Hamadi, Ali Abdelhay, Kanhaiya Singh
  PLOS ONE.2021; 16(10): e0257857.     CrossRef
• Misregulation of Wnt Signaling Pathways at the Plasma Membrane in Brain and Metabolic Diseases
  Mustafa Karabicici, Yagmur Azbazdar, Evin Iscan, Gunes Ozhan
  Membranes.2021; 11(11): 844.     CrossRef
• CD36 Signal Transduction in Metabolic Diseases: Novel Insights and Therapeutic Targeting
  Udayakumar Karunakaran, Suma Elumalai, Jun-Sung Moon, Kyu-Chang Won
  Cells.2021; 10(7): 1833.     CrossRef

As a member of the class IIa histone deacetylases (HDACs), HDAC9 catalyzes the deacetylation of histones and transcription factors, commonly leading to the suppression of gene transcription. The activity of HDAC9 is regulated transcriptionally and post-translationally. HDAC9 is known to play an essential role in regulating myocyte and adipocyte differentiation and cardiac muscle development. Also, recent studies have suggested that HDAC9 is involved in the pathogenesis of chronic diseases, including cardiovascular diseases, osteoporosis, autoimmune disease, cancer, obesity, insulin resistance, and liver fibrosis. HDAC9 modulates the expression of genes related to the pathogenesis of chronic diseases by altering chromatin structure in their promotor region or reducing the transcriptional activity of their respective transcription factors. This review summarizes the current knowledge of the regulation of HDAC9 expression and activity. Also, the roles of HDAC9 in the pathogenesis of chronic diseases are discussed, along with potential underlying mechanisms.

Citations

Citations to this article as recorded by  

• Impact of housing temperature on adipose tissue HDAC9 expression and adipogenic differentiation in high fat‐fed mice
  Samah Ahmadieh, Brandee Goo, Abdalrahman Zarzour, David Kim, Hong Shi, Praneet Veerapaneni, Ronnie Chouhaita, Nicole K. H. Yiew, Carla Dominguez Gonzalez, Akash Chakravartty, James Pennoyer, Nazeera Hassan, Tyler W. Benson, Mourad Ogbi, David J. Fulton, R
  Obesity.2024; 32(1): 107.     CrossRef
• HDAC9 inhibition reduces skeletal muscle atrophy and enhances regeneration in mice with cigarette smoke-induced COPD
  Guixian Zheng, Chao Li, Xiaoli Chen, Zhaohui Deng, Ting Xie, Zengyu Huo, Xinyan Wei, Yanbing Huang, Xia Zeng, Yu Luo, Jing Bai
  Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2024; 1870(3): 167023.     CrossRef
• Identification of HDAC9 and ARRDC4 as potential biomarkers and targets for treatment of type 2 diabetes
  Jing Liu, Lingzhen Meng, Zhihong Liu, Ming Lu, Ruiying Wang
  Scientific Reports.2024;[Epub]     CrossRef
• HDAC9 as a Privileged Target: Reviewing its Role in Different Diseases and Structure-activity Relationships (SARs) of its Inhibitors
  Totan Das, Samima Khatun, Tarun Jha, Shovanlal Gayen
  Mini-Reviews in Medicinal Chemistry.2024; 24(7): 767.     CrossRef
• The role of histone deacetylases in inflammatory respiratory diseases: an update
  Sicen Pan, Xiangdong Wang, Jian Jiao, Luo Zhang
  Expert Review of Clinical Immunology.2024; 20(10): 1193.     CrossRef
• The Human Genetic Differences in the Outcomes of mRNA Vaccination against COVID-19: A Prospective Cohort Study
  Ha-Eun Ryu, Jihyun Yoon, Ja-Eun Choi, Seok-Jae Heo, Kyung-Won Hong, Dong-Hyuk Jung
  Vaccines.2024; 12(6): 626.     CrossRef
• Targeting histone deacetylases for cancer therapy: Trends and challenges
  Tao Liang, Fengli Wang, Reham M. Elhassan, Yongmei Cheng, Xiaolei Tang, Wengang Chen, Hao Fang, Xuben Hou
  Acta Pharmaceutica Sinica B.2023; 13(6): 2425.     CrossRef
• Therapeutic approach of natural products that treat osteoporosis by targeting epigenetic modulation
  Guokai Zhang, Zhenying Liu, Zihan Li, Bing Zhang, Pengyu Yao, Yun Qiao
  Frontiers in Genetics.2023;[Epub]     CrossRef
• Research Progress on Histone Deacetylase Inhibitors
  玉姜 汤
  Hans Journal of Medicinal Chemistry.2023; 11(02): 116.     CrossRef
• HDAC9 Inhibition as a Novel Treatment for Stroke
  Hugh S. Markus
  Stroke.2023; 54(12): 3182.     CrossRef
• Histone deacetylase 9 exacerbates podocyte injury in hyperhomocysteinemia through epigenetic repression of Klotho
  Min Liu, Yang Zhang, Ping Zhan, Wenjuan Sun, Chuanqiao Dong, Xiaohan Liu, Yujie Yang, Xiaojie Wang, Yusheng Xie, Chengjiang Gao, Huili Hu, Benkang Shi, Ziying Wang, Chun Guo, Fan Yi
  Pharmacological Research.2023; 198: 107009.     CrossRef
• Molecular mechanism and therapeutic potential of HDAC9 in intervertebral disc degeneration
  Ming Lei, Hui Lin, Deyao Shi, Pan Hong, Hui Song, Bomansaan Herman, Zhiwei Liao, Cao Yang
  Cellular & Molecular Biology Letters.2023;[Epub]     CrossRef
• Interindividual variability in transgene mRNA and protein production following adeno-associated virus gene therapy for hemophilia A
  Sylvia Fong, Bridget Yates, Choong-Ryoul Sihn, Aras N. Mattis, Nina Mitchell, Su Liu, Chris B. Russell, Benjamin Kim, Adebayo Lawal, Savita Rangarajan, Will Lester, Stuart Bunting, Glenn F. Pierce, K. John Pasi, Wing Yen Wong
  Nature Medicine.2022; 28(4): 789.     CrossRef
• Active RhoA Exerts an Inhibitory Effect on the Homeostasis and Angiogenic Capacity of Human Endothelial Cells
  Michael Hauke, Robert Eckenstaler, Anne Ripperger, Anna Ender, Heike Braun, Ralf A. Benndorf
  Journal of the American Heart Association.2022;[Epub]     CrossRef
• HDAC9 Contributes to Serous Ovarian Cancer Progression through Regulating Epithelial–Mesenchymal Transition
  Long Xu, Jian Wang, Buhan Liu, Jiaying Fu, Yuanxin Zhao, Sihang Yu, Luyan Shen, Xiaoyu Yan, Jing Su
  Biomedicines.2022; 10(2): 374.     CrossRef
• Common protein-coding variants influence the racing phenotype in galloping racehorse breeds
  Haige Han, Beatrice A. McGivney, Lucy Allen, Dongyi Bai, Leanne R. Corduff, Gantulga Davaakhuu, Jargalsaikhan Davaasambuu, Dulguun Dorjgotov, Thomas J. Hall, Andrew J. Hemmings, Amy R. Holtby, Tuyatsetseg Jambal, Badarch Jargalsaikhan, Uyasakh Jargalsaikh
  Communications Biology.2022;[Epub]     CrossRef
• Proposed minimal essential co-expression and physical interaction networks involved in the development of cognition impairment in human mid and late life
  Zahra Salehi, Masoud Arabfard, Omid Sadatpour, Mina Ohadi
  Neurological Sciences.2021; 42(3): 951.     CrossRef
• Emerging roles of SIRT6 in human diseases and its modulators
  Gang Liu, Haiying Chen, Hua Liu, Wenbo Zhang, Jia Zhou
  Medicinal Research Reviews.2021; 41(2): 1089.     CrossRef
• Quis Custodiet Ipsos Custodes (Who Controls the Controllers)? Two Decades of Studies on HDAC9
  Claudio Brancolini, Eros Di Giorgio, Luigi Formisano, Teresa Gagliano
  Life.2021; 11(2): 90.     CrossRef
• circ_0003204 Regulates Cell Growth, Oxidative Stress, and Inflammation in ox-LDL-Induced Vascular Endothelial Cells via Regulating miR-942-5p/HDAC9 Axis
  Huan Wan, Ting You, Wei Luo
  Frontiers in Cardiovascular Medicine.2021;[Epub]     CrossRef
• Histone deacetylase (HDAC) 9: versatile biological functions and emerging roles in human cancer
  Chun Yang, Stéphane Croteau, Pierre Hardy
  Cellular Oncology.2021; 44(5): 997.     CrossRef
• Dual HDAC/BRD4 inhibitors against cancer
  Negar Omidkhah, Farzin Hadizadeh, Razieh Ghodsi
  Medicinal Chemistry Research.2021; 30(10): 1822.     CrossRef
• miR‐211‐5p is down‐regulated and a prognostic marker in bladder cancer
  Weisheng Wang, Zhiming Liu, Xuegang Zhang, Junning Liu, Junqing Gui, Maorong Cui, Yong Li
  The Journal of Gene Medicine.2020;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Imatinib adherence prediction using machine learning approach in patients with gastrointestinal stromal tumor
  Li Liu, Ze Yu, Hefen Chen, Zhujun Gong, Xiao Huang, Linhua Chen, Ziying Fan, Jinyuan Zhang, Jiannan Yan, Hongkun Tian, Xiangyu Zeng, Zhiliang Chen, Peng Zhang, Hong Zhou
  Cancer.2024;[Epub]     CrossRef
• Performance of Diabetes and Kidney Disease Screening Scores in Contemporary United States and Korean Populations
  Liela Meng, Keun-Sang Kwon, Dae Jung Kim, Yong-ho Lee, Jeehyoung Kim, Abhijit V. Kshirsagar, Heejung Bang
  Diabetes & Metabolism Journal.2022; 46(2): 273.     CrossRef
• Unified framework for brain connectivity-based biomarkers in neurodegenerative disorders
  Sung-Woo Kim, Yeong-Hun Song, Hee Jin Kim, Young Noh, Sang Won Seo, Duk L. Na, Joon-Kyung Seong
  Frontiers in Neuroscience.2022;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Altered Metabolic Phenotypes and Hypothalamic Neuronal Activity Triggered by Sodium-Glucose Cotransporter 2 Inhibition (Diabetes Metab J 2023;47:784-95)
  Jae Hyun Bae
  Diabetes & Metabolism Journal.2024; 48(1): 157.     CrossRef
• GLP-1 increases preingestive satiation via hypothalamic circuits in mice and humans
  Kyu Sik Kim, Joon Seok Park, Eunsang Hwang, Min Jung Park, Hwa Yun Shin, Young Hee Lee, Kyung Min Kim, Laurent Gautron, Elizabeth Godschall, Bryan Portillo, Kyle Grose, Sang-Ho Jung, So Lin Baek, Young Hyun Yun, Doyeon Lee, Eunseong Kim, Jason Ajwani, Seo
  Science.2024; 385(6707): 438.     CrossRef
• Glucagon-like peptide 1 agonist and effects on reward behaviour: A systematic review
  Sebastian Badulescu, Aniqa Tabassum, Gia Han Le, Sabrina Wong, Lee Phan, Hartej Gill, Cristian-Daniel Llach, Roger S. McIntyre, Joshua Rosenblat, Rodrigo Mansur
  Physiology & Behavior.2024; 283: 114622.     CrossRef
• Clinical Consequences of Delayed Gastric Emptying With GLP-1 Receptor Agonists and Tirzepatide
  Ryan J Jalleh, Mark P Plummer, Chinmay S Marathe, Mahesh M Umapathysivam, Daniel R Quast, Christopher K Rayner, Karen L Jones, Tongzhi Wu, Michael Horowitz, Michael A Nauck
  The Journal of Clinical Endocrinology & Metabolism.2024;[Epub]     CrossRef
• Diabetes remission and relapse following an intensive metabolic intervention combining insulin glargine/lixisenatide, metformin and lifestyle approaches: Results of a randomised controlled trial
  Natalia McInnes, Stephanie Hall, Heather A. Lochnan, Stewart B. Harris, Zubin Punthakee, Ronald J. Sigal, Irene Hramiak, Mohammed Azharuddin, Joanne F. Liutkus, Jean‐François Yale, Farah Sultan, Ada Smith, Rose E. Otto, Diana Sherifali, Yan Yun Liu, Hertz
  Diabetes, Obesity and Metabolism.2023; 25(11): 3347.     CrossRef
• Glucagon-like peptide-1 analog therapy in rare genetic diseases: monogenic obesity, monogenic diabetes, and spinal muscular atrophy
  Hussein Zaitoon, Ronit Lubetzky, Achiya Z. Amir, Hadar Moran-Lev, Liora Sagi, Michal Yacobi-Bach, Ophir Borger, Efrat Chorna, Yael Lebenthal, Avivit Brener
  Acta Diabetologica.2023; 60(8): 1099.     CrossRef
• What can functional brain imaging teach us about remission of type 2 diabetes?
  Dhruti Hirani, Shahd Alabdulkader, Alexander. D. Miras, Victoria Salem
  Diabetic Medicine.2023;[Epub]     CrossRef
• Fasting oxyntomodulin, glicentin, and gastric inhibitory polypeptide levels are associated with activation of reward‐ and attention‐related brain centres in response to visual food cues in adults with obesity: A cross‐sectional functional MRI study
  Nikolaos Perakakis, Olivia M. Farr, Christos S. Mantzoros
  Diabetes, Obesity and Metabolism.2021; 23(5): 1202.     CrossRef
• Aberrant Brain Functional Connectivity Strength and Effective Connectivity in Patients with Type 2 Diabetes Mellitus
  Xi Guo, Su Wang, Yu-Chen Chen, Heng-Le Wei, Gang-Ping Zhou, Yu-Sheng Yu, Xindao Yin, Kun Wang, Hong Zhang, Eusebio Chiefari
  Journal of Diabetes Research.2021; 2021: 1.     CrossRef

Citations

Citations to this article as recorded by  

• 2. Diagnosis and Classification of Diabetes:Standards of Care in Diabetes—2024
  Nuha A. ElSayed, Grazia Aleppo, Raveendhara R. Bannuru, Dennis Bruemmer, Billy S. Collins, Laya Ekhlaspour, Jason L. Gaglia, Marisa E. Hilliard, Eric L. Johnson, Kamlesh Khunti, Ildiko Lingvay, Glenn Matfin, Rozalina G. McCoy, Mary Lou Perry, Scott J. Pil
  Diabetes Care.2024; 47(Supplement): S20.     CrossRef
• 2. Classification and Diagnosis of Diabetes:Standards of Care in Diabetes—2023
  Nuha A. ElSayed, Grazia Aleppo, Vanita R. Aroda, Raveendhara R. Bannuru, Florence M. Brown, Dennis Bruemmer, Billy S. Collins, Jason L. Gaglia, Marisa E. Hilliard, Diana Isaacs, Eric L. Johnson, Scott Kahan, Kamlesh Khunti, Jose Leon, Sarah K. Lyons, Mary
  Diabetes Care.2023; 46(Supplement): S19.     CrossRef
• Determination of autoantibodies in type 2 diabetes: one simple way to improve classification
  Johnny Ludvigsson
  Diabetologia.2023; 66(5): 955.     CrossRef
• 2. Classification and Diagnosis of Diabetes:Standards of Medical Care in Diabetes—2022
  
  Diabetes Care.2022; 45(Supplement): S17.     CrossRef
• Screening Strategy for Islet Autoantibodies in Diabetes Patients of Different Ages
  Xixi Nan, Xia Li, Yufei Xiang, Xiang Yan, Houde Zhou, Xiaohan Tang, Jin Cheng, Xiaohong Niu, Jing Liu, Qiuhe Ji, Linong Ji, Gan Huang, Zhiguang Zhou
  Diabetes Technology & Therapeutics.2022; 24(3): 212.     CrossRef
• Atypical Diabetes and Management Considerations
  Shivajirao Prakash Patil
  Primary Care: Clinics in Office Practice.2022; 49(2): 225.     CrossRef
• Latent autoimmune diabetes in adults: a focus on β-cell protection and therapy
  Wenfeng Yin, Shuoming Luo, Zilin Xiao, Ziwei Zhang, Bingwen Liu, Zhiguang Zhou
  Frontiers in Endocrinology.2022;[Epub]     CrossRef
• Analysis of detrended fluctuation function derived from continuous glucose monitoring may assist in distinguishing latent autoimmune diabetes in adults from T2DM
  Liyin Zhang, Qi Tian, Keyu Guo, Jieru Wu, Jianan Ye, Zhiyi Ding, Qin Zhou, Gan Huang, Xia Li, Zhiguang Zhou, Lin Yang
  Frontiers in Endocrinology.2022;[Epub]     CrossRef
• Prevalence of antibodies targeting ubiquitin-conjugating enzyme 2L3 and eukaryote translation elongation factor 1 α1 in Chinese Han and American Caucasian populations with type 1 diabetes
  Li Qian, Yuxiao Zhu, Yan Luo, Mu Zhang, Liping Yu, Yu Liu, Tao Yang
  Endocrine Connections.2022;[Epub]     CrossRef
• 2. Classification and Diagnosis of Diabetes:Standards of Medical Care in Diabetes—2021
  
  Diabetes Care.2021; 44(Supplement): S15.     CrossRef
• High-Affinity ZnT8 Autoantibodies by Electrochemiluminescence Assay Improve Risk Prediction for Type 1 Diabetes
  Xiaofan Jia, Ling He, Dongmei Miao, Kathleen Waugh, Cristy Geno Rasmussen, Fran Dong, Andrea K Steck, Marian Rewers, Liping Yu
  The Journal of Clinical Endocrinology & Metabolism.2021;[Epub]     CrossRef
• Lada or Type 2 Diabetes Mellitus - A Challenging Diagnosis in Clinical Approach
  Lucia Mihaela Custură, Oana Deteşan, Raluca Maria Tilinca, Reka Annamaria Schmiedt, Brigitta Irén Bacso, Mariana Cornelia Tilinca
  Acta Medica Transilvanica.2021; 26(3): 55.     CrossRef
• A fluorescence enhancement assay for measurement of glutamate decarboxylase activity
  Messripour Manoochehr, Mesripour Azadeh
  Open Journal of Analytical and Bioanalytical Chemistry.2020; : 007.     CrossRef

Citations

Citations to this article as recorded by  

• Anti-hepatopathy and anti-nephropathy activities of Taraxacum officinale in a rat model of Streptozotocin diabetes-induced hepatorenal toxicity and dyslipidemia via attenuation of oxidative stress, inflammation, apoptosis, electrolyte imbalances, and mito
  Sunday Aderemi Adelakun, Aniah Julius Akomaye, Olusegun Dare Omotoso, Olukayode Abimbola Arowosegbe
  Aspects of Molecular Medicine.2024; 3: 100034.     CrossRef
• Epidemiology of heart failure in diabetes: a disease in disguise
  Anna G. Hoek, Elisa Dal Canto, Eva Wenker, Navin Bindraban, M. Louis Handoko, Petra J. M. Elders, Joline W. J. Beulens
  Diabetologia.2024; 67(4): 574.     CrossRef
• NASH triggers cardiometabolic HFpEF in aging mice
  Dániel Kucsera, Mihály Ruppert, Nabil V. Sayour, Viktória E. Tóth, Tamás Kovács, Zsombor I. Hegedűs, Zsófia Onódi, Alexandra Fábián, Attila Kovács, Tamás Radovits, Béla Merkely, Pál Pacher, Péter Ferdinandy, Zoltán V. Varga
  GeroScience.2024; 46(5): 4517.     CrossRef
• Inhibition of visceral adipose tissue-derived pathogenic signals by activation of adenosine A2AR improves hepatic and cardiac dysfunction of NASH mice
  Chia-Chang Huang, Hsiao-Yun Yeh, Roger Lin, Tsai-Ling Liao, Hsiao-Chin Shen, Ying-Ying Yang, Han-Chieh Lin
  American Journal of Physiology-Gastrointestinal and Liver Physiology.2024; 326(4): G385.     CrossRef
• Metabolic dysfunction-associated steatotic liver disease-associated fibrosis and cardiac dysfunction in patients with type 2 diabetes
  Simona Cernea, Danusia Onișor, Andrada Larisa Roiban, Theodora Benedek, Nora Rat
  World Journal of Cardiology.2024; 16(10): 580.     CrossRef
• Is non-alcoholic fatty liver disease a sign of left ventricular diastolic dysfunction in patients with type 2 diabetes mellitus? A systematic review and meta-analysis
  Sicheng Wang, Xiangyuan Zhang, Qiqi Zhang, Boxun Zhang, Linhua Zhao
  BMJ Open Diabetes Research & Care.2023; 11(1): e003198.     CrossRef
• The effect of metabolic dysfunction-associated fatty liver disease and diabetic kidney disease on the risk of hospitalization of heart failure in type 2 diabetes: a retrospective cohort study
  Seung Eun Lee, Juhwan Yoo, Bong-Seong Kim, Han Seok Choi, Kyungdo Han, Kyoung-Ah Kim
  Diabetology & Metabolic Syndrome.2023;[Epub]     CrossRef
• Metabolic Dysfunction-Associated Fatty Liver Disease and Mortality: A Population-Based Cohort Study
  Kyung-Soo Kim, Sangmo Hong, Hong-Yup Ahn, Cheol-Young Park
  Diabetes & Metabolism Journal.2023; 47(2): 220.     CrossRef
• Therapies for patients with coexisting heart failure with reduced ejection fraction and non-alcoholic fatty liver disease
  Jose Arriola-Montenegro, Renato Beas, Renato Cerna-Viacava, Andres Chaponan-Lavalle, Karla Hernandez Randich, Diego Chambergo-Michilot, Herson Flores Sanga, Pornthira Mutirangura
  World Journal of Cardiology.2023; 15(7): 328.     CrossRef
• Non-alcoholic Fatty Liver Disease and Its Association With Left Ventricular Diastolic Dysfunction: A Systematic Review
  Namra V Gohil, Nida Tanveer, Vijaya Krishna Makkena, Arturo P Jaramillo, Babatope L Awosusi, Javaria Ayyub, Karan Nareshbhai Dabhi, Tuheen Sankar Nath
  Cureus.2023;[Epub]     CrossRef
• Associations of advanced liver fibrosis with heart failure with preserved ejection fraction in type 2 diabetic patients according to obesity and metabolic goal achievement status
  Wangyan Jiang, Zhelong Liu, Shaohua Liu, Tingting Du
  Frontiers in Endocrinology.2023;[Epub]     CrossRef
• Non-Alcoholic Fatty Liver Disease and Echocardiographic Parameters of Left Ventricular Diastolic Function: A Systematic Review and Meta-Analysis
  Athina Goliopoulou, Panagiotis Theofilis, Evangelos Oikonomou, Artemis Anastasiou, Panteleimon Pantelidis, Maria Ioanna Gounaridi, Georgios E. Zakynthinos, Ourania Katsarou, Eva Kassi, Vaia Lambadiari, Dimitris Tousoulis, Manolis Vavuranakis, Gerasimos Si
  International Journal of Molecular Sciences.2023; 24(18): 14292.     CrossRef
• Non-alcoholic fatty liver disease and risk of cardiovascular diseases: clinical association, pathophysiological mechanisms, and management
  Rong Yang, Jian-Gao Fan
  Cardiology Plus.2023; 8(4): 217.     CrossRef
• Association of cardiovascular factors in diabetic patients with non-alcoholic fatty liver disease
  Evangelos Cholongitas, Dimitrios Tsilingiris, Panagiota Diamantopoulou, Elpida Mastrogianni, Anastasios Tentolouris, Dimitrios Karagiannakis, Ioannis Moyssakis, George V. Papatheodoridis, Nikolaos Tentolouris
  Hormones.2022; 21(1): 133.     CrossRef
• Non-alcoholic fatty liver disease association with structural heart, systolic and diastolic dysfunction: a meta-analysis
  Jie Ning Yong, Cheng Han Ng, Chloe Wen-Min Lee, Yu Yi Chan, Ansel Shao Pin Tang, Margaret Teng, Darren Jun Hao Tan, Wen Hui Lim, Jingxuan Quek, Jieling Xiao, Yip Han Chin, Roger Foo, Mark Chan, Weiqin Lin, Mazen Noureddin, Mohammad Shadab Siddiqui, Mark D
  Hepatology International.2022; 16(2): 269.     CrossRef
• Triglyceride and glucose index is a simple and easy‐to‐calculate marker associated with nonalcoholic fatty liver disease
  Kyung‐Soo Kim, Sangmo Hong, Hong‐Yup Ahn, Cheol‐Young Park
  Obesity.2022; 30(6): 1279.     CrossRef
• Association of Metabolic Dysfunction-Associated Fatty Liver Disease With Left Ventricular Diastolic Function and Cardiac Morphology
  Dandan Peng, Zhenqiu Yu, Mingwei Wang, Junping Shi, Lei Sun, Yuanyuan Zhang, Wenbin Zhao, Chen Chen, Jiake Tang, Chunyi Wang, Jie Ni, Wen Wen, Jingjie Jiang
  Frontiers in Endocrinology.2022;[Epub]     CrossRef
• NAFLD in Cardiovascular Diseases: A Contributor or Comorbidity?
  Bing Chen, W.H. Wilson Tang, Mario Rodriguez, Kathleen E. Corey, Arun J. Sanyal, Patrick S. Kamath, Biykem Bozkurt, Hafeez Ul Hassan Virk, Gregg S. Pressman, Jeffrey V. Lazarus, Hashem B. El-Serag, Chayakrit Krittanawong
  Seminars in Liver Disease.2022; 42(04): 465.     CrossRef
• Nonalcoholic fatty liver disease is associated with early left ventricular diastolic dysfunction in patients with type 2 diabeteS
  Walaa Sheba, Eman Morsy, Salah Altahan, Mona Ayaad, Sameh A. Lashen
  Alexandria Journal of Medicine.2022; 58(1): 117.     CrossRef
• Cardiac abnormalities in patients with nonalcoholic fatty liver disease
  Yu Dong, Guangsen Li
  Herz.2021; 46(2): 158.     CrossRef
• Elafibranor improves diet-induced nonalcoholic steatohepatitis associated with heart failure with preserved ejection fraction in Golden Syrian hamsters
  François Briand, Julie Maupoint, Emmanuel Brousseau, Natalia Breyner, Mélanie Bouchet, Clément Costard, Thierry Leste-Lasserre, Mathieu Petitjean, Li Chen, Audrey Chabrat, Virgile Richard, Rémy Burcelin, Caroline Dubroca, Thierry Sulpice
  Metabolism.2021; 117: 154707.     CrossRef
• Association of the Non‐Alcoholic Fatty Liver Disease Fibrosis Score with subclinical myocardial remodeling in patients with type 2 diabetes: A cross‐sectional study in China
  Nengguang Fan, Xiaoying Ding, Qin Zhen, Liping Gu, Aifang Zhang, Tingting Shen, Yufan Wang, Yongde Peng
  Journal of Diabetes Investigation.2021; 12(6): 1035.     CrossRef
• Nonalcoholic fatty liver disease, diastolic dysfunction, and impaired myocardial glucose uptake in patients with type 2 diabetes
  Minyoung Lee, Kwang Joon Kim, Tae‐Ha Chung, Jaehyun Bae, Yong‐ho Lee, Byung‐Wan Lee, Bong‐Soo Cha, Mijin Yun, Eun Seok Kang
  Diabetes, Obesity and Metabolism.2021; 23(4): 1041.     CrossRef
• Interplay between Heart Disease and Metabolic Steatosis: A Contemporary Perspective
  Mohammad Said Ramadan, Vincenzo Russo, Gerardo Nigro, Emanuele Durante-Mangoni, Rosa Zampino
  Journal of Clinical Medicine.2021; 10(8): 1569.     CrossRef
• Correlation Between 25-Hydroxyvitamin D Level and Cardiac Diastolic Dysfunction in Chinese Adults with Early-Onset Type 2 Diabetes Mellitus: A Cross-Sectional Study
  Lei Xiu, Xiao-ai Yao, Tao Jiang
  Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2021; Volume 14: 1823.     CrossRef
• Bi-directional and temporal relationship between elevated alanine aminotransferase and hypertension in a longitudinal study of Chinese adults
  Guoxin Huang, Hui Zhou, Chao Shen, Yihui Sheng, Ruyu Xue, Chen Dong, Shaoyan Zhang
  Clinical and Experimental Hypertension.2021; 43(8): 750.     CrossRef
• Response: Association between Non-Alcoholic Steatohepatitis and Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Mellitus (Diabetes Metab J 2020;44:267–76)
  Hokyou Lee, Gyuri Kim, Yong-ho Lee
  Diabetes & Metabolism Journal.2020; 44(3): 486.     CrossRef
• Letter: Association between Non-Alcoholic Steatohepatitis and Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Mellitus (Diabetes Metab J2020;44:267–76)
  Sung Hoon Yu
  Diabetes & Metabolism Journal.2020; 44(3): 482.     CrossRef

Citations

Citations to this article as recorded by  

• Associations of Serum Uric Acid to High-Density Lipoprotein Cholesterol Ratio with Trunk Fat Mass and Visceral Fat Accumulation
  Yansu Wang, Yiting Xu, Tingting Hu, Yunfeng Xiao, Yufei Wang, Xiaojing Ma, Haoyong Yu, Yuqian Bao
  Diabetes, Metabolic Syndrome and Obesity.2024; Volume 17: 121.     CrossRef
• Impact of the COVID-19 Pandemic on Obesity, Metabolic Parameters and Clinical Values in the South Korean Adult Population
  Anna Kim, Eun-yeob Kim, Jaeyoung Kim
  Journal of Clinical Medicine.2024; 13(10): 2814.     CrossRef
• Obesity-related parameters in carriers of some BDNF genetic variants may depend on daily dietary macronutrients intake
  Urszula Miksza, Edyta Adamska-Patruno, Witold Bauer, Joanna Fiedorczuk, Przemyslaw Czajkowski, Monika Moroz, Krzysztof Drygalski, Andrzej Ustymowicz, Elwira Tomkiewicz, Maria Gorska, Adam Kretowski
  Scientific Reports.2023;[Epub]     CrossRef
• Computed tomography-based investigation of the correlation of abdominal fat areas with metabolic syndrome
  Kai-Yuan Cheng, Tsung-Hsien Yen, Jay Wu, Pei-Hsuan Li, Tian-Yu Shih
  Journal of Radiological Science.2023; 48(1): 15.     CrossRef
• Lower High-Density Lipoprotein Cholesterol Concentration Is Independently Associated with Greater Future Accumulation of Intra-Abdominal Fat
  Sun Ok Song, You-Cheol Hwang, Han Uk Ryu, Steven E. Kahn, Donna L. Leonetti, Wilfred Y. Fujimoto, Edward J. Boyko
  Endocrinology and Metabolism.2021; 36(4): 835.     CrossRef

Citations

Citations to this article as recorded by  

• Postprandial Free Fatty Acids at Mid-Pregnancy Increase the Risk of Large-for-Gestational-Age Newborns in Women with Gestational Diabetes Mellitus
  So-Yeon Kim, Young Shin Song, Soo-Kyung Kim, Yong-Wook Cho, Kyung-Soo Kim
  Diabetes & Metabolism Journal.2022; 46(1): 140.     CrossRef
• Unraveling the Factors Determining Development of Type 2 Diabetes in Women With a History of Gestational Diabetes Mellitus Through Machine-Learning Techniques
  Ludovica Ilari, Agnese Piersanti, Christian Göbl, Laura Burattini, Alexandra Kautzky-Willer, Andrea Tura, Micaela Morettini
  Frontiers in Physiology.2022;[Epub]     CrossRef
• The Clinical Characteristics of Gestational Diabetes Mellitus in Korea: A National Health Information Database Study
  Kyung-Soo Kim, Sangmo Hong, Kyungdo Han, Cheol-Young Park
  Endocrinology and Metabolism.2021; 36(3): 628.     CrossRef

Citations

Citations to this article as recorded by  

• The association between retinol-binding protein 4 and risk of type 2 diabetes: A systematic review and meta-analysis
  Xiaomeng Tan, Han Zhang, Limin Liu, Zengli Yu, Xinxin Liu, Lingling Cui, Yao Chen, Huanhuan Zhang, Zhan Gao, Zijian Zhao
  International Journal of Environmental Health Research.2024; 34(2): 1053.     CrossRef
• Baseline glycated albumin level and risk of type 2 diabetes mellitus in Healthy individuals: a retrospective longitudinal observation in Korea
  Kang-Su Shin, Min-Seung Park, Mi Yeon Lee, Eun Hye Cho, Hee-Yeon Woo, Hyosoon Park, Min-Jung Kwon
  Scandinavian Journal of Clinical and Laboratory Investigation.2024; 84(3): 168.     CrossRef
• Are Oxidative Stress Biomarkers Reliable Part of Multimarker Panel in Female Patients with Type 2 Diabetes Mellitus?
  Aleksandra Klisic, Paschalis Karakasis, Dimitrios Patoulias, Amirmohammad Khalaji, Ana Ninić
  Metabolic Syndrome and Related Disorders.2024; 22(9): 679.     CrossRef
• Development and evaluation of a chronic kidney disease risk prediction model using random forest
  Krish Mendapara
  Frontiers in Genetics.2024;[Epub]     CrossRef
• Remnant Cholesterol Is an Independent Predictor of Type 2 Diabetes: A Nationwide Population-Based Cohort Study
  Ji Hye Huh, Eun Roh, Seong Jin Lee, Sung-Hee Ihm, Kyung-Do Han, Jun Goo Kang
  Diabetes Care.2023; 46(2): 305.     CrossRef
• A FRAMEWORK FOR THE ANALYSIS OF COMORBID CONDITIONS USING INTELLIGENT EXTRACTION OF MULTIPLE FLUID BIOMARKERS
  PRIYANKA JADHAV, VINOTHINI SELVARAJU, SARITH P SATHIAN, RAMAKRISHNAN SWAMINATHAN
  Journal of Mechanics in Medicine and Biology.2023;[Epub]     CrossRef
• Strikes and Gutters: Biomarkers and anthropometric measures for predicting diagnosed diabetes mellitus in adults in low- and middle-income countries
  Sally Sonia Simmons
  Heliyon.2023; 9(9): e19494.     CrossRef
• Association of IL-16 rs11556218 T/G polymorphism with the risk of developing type 2 diabetes mellitus
  Dalia Ghareeb Mohammad, Hamdy Omar, Taghrid B. El-Abaseri, Wafaa Omar, Shaymaa Abdelraheem
  Journal of Diabetes & Metabolic Disorders.2021; 20(1): 649.     CrossRef
• Biomarker Score in Risk Prediction: Beyond Scientific Evidence and Statistical Performance
  Heejung Bang
  Diabetes & Metabolism Journal.2020; 44(2): 245.     CrossRef

Citations

Citations to this article as recorded by  

• An application of the Bayesian network model based on the EN-ESL-GA algorithm: Exploring the predictors of heart disease in middle-aged and elderly people in China
  Wenlong Gao, Zhimei Zeng, Xiaojie Ma, Yongsong Ke, Minqian Zhi
  Technology and Health Care.2024; 32(6): 3903.     CrossRef
• Higher atherogenic index of plasma is associated with increased major depressive disorder: insights from a nationally representative study
  Shiyi Tao, Lintong Yu, Jun Li, Xuanchun Huang, Tiantian Xue, Deshuang Yang, Yuqing Tan
  Frontiers in Psychiatry.2024;[Epub]     CrossRef
• Elevated remnant cholesterol and the risk of prevalent major depressive disorder: a nationwide population-based study
  Shiyi Tao, Lintong Yu, Jun Li, Ji Wu, Deshuang Yang, Xuanchun Huang, Tiantian Xue
  Frontiers in Psychiatry.2024;[Epub]     CrossRef
• Mediating effect of depression on the association between cardiovascular disease and the risk of all‐cause mortality: NHANES in 2005−2018
  Xinxin Ma, Huan Zhang, Yuan Tian, Yaping Wang, Ling Liu, Lei Wang
  Clinical Cardiology.2023; 46(11): 1380.     CrossRef
• Associations of sleep duration, daytime napping, and snoring with depression in rural China: a cross-sectional study
  Xueyao Zhang, Guangxiao Li, Chuning Shi, Yingxian Sun
  BMC Public Health.2023;[Epub]     CrossRef
• Association between socioeconomic inequality and the global prevalence of anxiety and depressive disorders: an ecological study
  Fatemeh Shahbazi, Marjan Shahbazi, Jalal Poorolajal
  General Psychiatry.2022; 35(3): e100735.     CrossRef
• Impact of Alexithymia on the Lipid Profile in Major Depressed Individuals
  Camille Point, Benjamin Wacquier, Marjorie Dosogne, Mohammed Al Faker, Hadrien Willame, Gwenolé Loas, Matthieu Hein, Philip W. Wertz
  Journal of Lipids.2022; 2022: 1.     CrossRef
• Association of Depression With Cardiovascular Diseases
  Zain I Warriach, Sruti Patel, Fatima Khan, Gerardo F Ferrer
  Cureus.2022;[Epub]     CrossRef
• Fenofibrate add-on to statin treatment is associated with low all-cause death and cardiovascular disease in the general population with high triglyceride levels
  Kyung-Soo Kim, Sangmo Hong, Kyungdo Han, Cheol-Young Park
  Metabolism.2022; 137: 155327.     CrossRef
• Dyslipidemia prevalence and trends among adult mental disorder inpatients in Beijing, 2005–2018: A longitudinal observational study
  Fude Yang, Qiuyue Ma, Botao Ma, Wenzhan Jing, Jue Liu, Moning Guo, Juan Li, Zhiren Wang, Min Liu
  Asian Journal of Psychiatry.2021; 57: 102583.     CrossRef
• Non-HDL cholesterol level and depression among Canadian elderly—a cross-sectional analysis of the baseline data from the CLSA
  Jian Liu, Surim Son, Mike Giancaterino, Chris P. Verschoor, Miya Narushima, David Moher
  FACETS.2020; 5(1): 1006.     CrossRef

Citations

Citations to this article as recorded by  

• Explanatory variables of objectively measured 24-h movement behaviors in people with prediabetes and type 2 diabetes: A systematic review
  Lotte Bogaert, Iris Willems, Patrick Calders, Eveline Dirinck, Manon Kinaupenne, Marga Decraene, Bruno Lapauw, Boyd Strumane, Margot Van Daele, Vera Verbestel, Marieke De Craemer
  Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2024; 18(4): 102995.     CrossRef
• Association between depression, anemia and physical activity using isotemporal substitution analysis
  Hee-kyoung Nam, Jungmi Park, Sung-il Cho
  BMC Public Health.2023;[Epub]     CrossRef
• The Impact of Wearable Technologies in Health Research: Scoping Review
  Sophie Huhn, Miriam Axt, Hanns-Christian Gunga, Martina Anna Maggioni, Stephen Munga, David Obor, Ali Sié, Valentin Boudo, Aditi Bunker, Rainer Sauerborn, Till Bärnighausen, Sandra Barteit
  JMIR mHealth and uHealth.2022; 10(1): e34384.     CrossRef
• The Correlation of Prediabetes and Type 2 Diabetes With Adiposity in Adults
  Juan Sun, Zhen Liu, Zimu Zhang, Ziyang Zeng, Weiming Kang
  Frontiers in Nutrition.2022;[Epub]     CrossRef
• The Physical Activity Assessment of Adults With Type 2 Diabetes Using Accelerometer-Based Cut Points: Scoping Review
  Ioana A Moldovan, Alexa Bragg, Anna S Nidhiry, Barbara A De La Cruz, Suzanne E Mitchell
  Interactive Journal of Medical Research.2022; 11(2): e34433.     CrossRef
• Effects of 4 Weeks of a Technique-Specific Protocol with High-Intensity Intervals on General and Specific Physical Fitness in Taekwondo Athletes: An Inter-Individual Analysis
  Alex Ojeda-Aravena, Tomás Herrera-Valenzuela, Pablo Valdés-Badilla, Jorge Cancino-López, José Zapata-Bastias, José Manuel García-García
  International Journal of Environmental Research and Public Health.2021; 18(7): 3643.     CrossRef
• Inter-Individual Variability of a High-Intensity Interval Training With Specific Techniques vs. Repeated Sprints Program in Sport-Related Fitness of Taekwondo Athletes
  Alex Ojeda-Aravena, Tomás Herrera-Valenzuela, Pablo Valdés-Badilla, Jorge Cancino-López, José Zapata-Bastias, José Manuel García-García
  Frontiers in Physiology.2021;[Epub]     CrossRef
• EFFECT OF SPORTS MEDICINE ON REDUCING BODY FAT PERCENTAGE AND LEAN BODY MASS
  Chunyan Fan
  Revista Brasileira de Medicina do Esporte.2021; 27(7): 714.     CrossRef
• Validation of the effectiveness of a digital integrated healthcare platform utilizing an AI-based dietary management solution and a real-time continuous glucose monitoring system for diabetes management: a randomized controlled trial
  Sung Woon Park, Gyuri Kim, You-Cheol Hwang, Woo Je Lee, Hyunjin Park, Jae Hyeon Kim
  BMC Medical Informatics and Decision Making.2020;[Epub]     CrossRef
• Brain activity during a working memory task in different postures: an EEG study
  Ju-Yeon Jung, Hwi-Young Cho, Chang-Ki Kang
  Ergonomics.2020; 63(11): 1359.     CrossRef

Citations

Citations to this article as recorded by  

• Insights on effects of Wnt pathway modulation on insulin signaling and glucose homeostasis for the treatment of type 2 diabetes mellitus: Wnt activation or Wnt inhibition?
  Ruchi Yadav, Bhumika Patel
  International Journal of Biological Macromolecules.2024; 261: 129634.     CrossRef
• Evaluating the correlation of sclerostin levels with obesity and type 2 diabetes in a multiethnic population living in Kuwait
  Tahani Alramah, Preethi Cherian, Irina Al-Khairi, Mohamed Abu-Farha, Thangavel Alphonse Thanaraj, Ahmed N. Albatineh, Fayez Safadi, Hamad Ali, Muhammad Abdul-Ghani, Jaakko Tuomilehto, Heikki A. Koistinen, Fahd Al-Mulla, Jehad Abubaker
  Frontiers in Endocrinology.2024;[Epub]     CrossRef
• The role of the Wnt signalling pathway in the energy metabolism of bone remodelling
  Mengyuan Zhu, Zhipeng Fan
  Cell Proliferation.2022;[Epub]     CrossRef
• Transcriptomic analysis provides a new insight: Oleuropein reverses high glucose-induced osteogenic inhibition in bone marrow mesenchymal stem cells via Wnt10b activation
  An Lao, Yu Chen, Yiting Sun, Tiange Wang, Kaili Lin, Jiaqiang Liu, Jianyong Wu
  Frontiers in Bioengineering and Biotechnology.2022;[Epub]     CrossRef
• Subcutaneous adipose tissue sclerostin is reduced and Wnt signaling is enhanced following 4‐weeks of sprint interval training in young men with obesity
  Nigel Kurgan, Hashim Islam, Jennifer B. L. Matusiak, Bradley J. Baranowski, Joshua Stoikos, Val A. Fajardo, Rebecca E. K. MacPherson, Brendon J. Gurd, Panagiota Klentrou
  Physiological Reports.2022;[Epub]     CrossRef
• Circulating Levels of Sclerostin Predict Glycemic Improvement after Sleeve Gastrectomy
  Federico Carbone, Elisa Nulli Migliola, Aldo Bonaventura, Alessandra Vecchié, Stefano De Vuono, Maria Anastasia Ricci, Gaetano Vaudo, Marcello Boni, Stefano Ministrini, Graziana Lupattelli, Fabrizio Montecucco
  Nutrients.2021; 13(2): 623.     CrossRef
• Serum sclerostin concentration is associated with specific adipose, muscle and bone tissue markers in lean adolescent females with increased physical activity
  Jaak Jürimäe, Vita Karvelyte, Liina Remmel, Anna-Liisa Tamm, Priit Purge, Rita Gruodyte-Raciene, Sigitas Kamandulis, Katre Maasalu, Luis Gracia-Marco, Vallo Tillmann
  Journal of Pediatric Endocrinology and Metabolism.2021; 34(6): 755.     CrossRef
• The complex role of Wnt ligands in type 2 diabetes mellitus and related complications
  Xiaobo Nie, Xiaoyun Wei, Han Ma, Lili Fan, Wei‐Dong Chen
  Journal of Cellular and Molecular Medicine.2021; 25(14): 6479.     CrossRef

Citations

Citations to this article as recorded by  

• Bifidobacterium bifidum BGN4 fractions ameliorate palmitic acid-induced hepatocyte ferroptosis by inhibiting SREBP1-CYP2E1 pathway
  Guangkui Bu, Gang Chen, Juan Li, Dan Wu, Jiangtao Liao
  Journal of Investigative Medicine.2024; 72(1): 67.     CrossRef
• Docosahexaenoic acid (DHA) alleviates hepatic lipid accumulation by regulating mitochondrial quality control through ERK signaling pathway in grass carp (Ctenopharyngodon idellus)
  Chenchen Bian, Shanghong Ji, Caihong Zeng, Jian Sun, Gen Kaneko, Hong Ji
  Aquaculture.2024; 579: 740209.     CrossRef
• Characterisation and skin protection activities of polysaccharides from Schnabelia terniflora
  Ying Zhao, Yixian Liu, Huoxiang Zhou, Wei Guo, Weidong Wang, Huiping Chen
  Natural Product Research.2024; 38(23): 4191.     CrossRef
• Association of lipid-lowering drugs with gut microbiota: A Mendelian randomization study
  Lubo Shi, Xiaoduo Liu, Enze Li, Shutian Zhang, Anni Zhou
  Journal of Clinical Lipidology.2024; 18(5): e797.     CrossRef
• Microbial-Based Bioactive Compounds to Alleviate Inflammation in Obesity
  Oladayo Emmanuel Apalowo, Grace Adeola Adegoye, Tolulope Mobolaji Obuotor
  Current Issues in Molecular Biology.2024; 46(3): 1810.     CrossRef
• Understanding the role of ursodeoxycholic acid and gut microbiome in non-alcoholic fatty liver disease: current evidence and perspectives
  Qingyi Mao, Beibei Lin, Wenluo Zhang, Yu Zhang, Yu Zhang, Qian Cao, Mengque Xu
  Frontiers in Pharmacology.2024;[Epub]     CrossRef
• Smilax China L. polysaccharide prevents HFD induced-NAFLD by regulating hepatic fat metabolism and gut microbiota
  Wenkai Zhang, Longhui Yu, Qinru Yang, Jinfeng Zhang, Wenjing Wang, Xinru Hu, Jingen Li, Guodong Zheng
  Phytomedicine.2024; 127: 155478.     CrossRef
• Breaking the barriers: the role of gut homeostasis in Metabolic-Associated Steatotic Liver Disease (MASLD)
  Raquel Benedé-Ubieto, Francisco Javier Cubero, Yulia A. Nevzorova
  Gut Microbes.2024;[Epub]     CrossRef
• Prospect of research on anti-atherosclerosis effect of main components of traditional Chinese medicine Yiqi Huoxue Huatan recipe through gut microbiota: A review
  Hongtao Huang, Hanjun Zhao, Lv Wenqing, Feiyue Xu, Xiaolong Wang, Yili Yao, Yu Huang
  Medicine.2024; 103(5): e37104.     CrossRef
• Polysaccharides from Eucommia ulmoides Oliv. Leaves Alleviate Acute Alcoholic Liver Injury by Modulating the Microbiota–Gut–Liver Axis in Mice
  Yingzhi Li, Huimei Wang, Xueping Leng, Jiaming Gao, Chang Li, Danfei Huang
  Foods.2024; 13(7): 1089.     CrossRef
• Innovative pharmacotherapy for hepatic metabolic and chronic inflammatory diseases in China
  Feng Zhang, Jiaming Ju, Hongtao Diao, Jinglun Song, Yu bian, Baofeng Yang
  British Journal of Pharmacology.2024;[Epub]     CrossRef
• Shenling Baizhu San ameliorates non-alcoholic fatty liver disease in mice by modulating gut microbiota and metabolites
  Dongliang Chen, Yuanfei Wang, Jianmei Yang, Wanyi Ou, Guiru Lin, Ze Zeng, Xiaomin Lu, Zumin Chen, Lili Zou, Yaling Tian, Aiping Wu, Shelley E. Keating, Qinhe Yang, Chenli Lin, Yinji Liang
  Frontiers in Pharmacology.2024;[Epub]     CrossRef
• Berberine alleviates high-energy and low-protein diet-induced fatty liver hemorrhagic syndrome in laying hens: insights from microbiome and metabolomics
  Xinyi Cheng, Yang Hu, Jun Kuang, Xiaoquan Guo, Huabin Cao, Huansheng Wu, Guoliang Hu, Yu Zhuang
  Poultry Science.2024; 103(8): 103968.     CrossRef
• Gut–Liver–Pancreas Axis Crosstalk in Health and Disease: From the Role of Microbial Metabolites to Innovative Microbiota Manipulating Strategies
  Giada Marroncini, Laura Naldi, Serena Martinelli, Amedeo Amedei
  Biomedicines.2024; 12(7): 1398.     CrossRef
• The molecular and network mechanisms of antilipidemic potential effects of Ganfule capsules in nonalcoholic fatty liver disease
  Yu Pan, Liya Qiao, Yunkun Zhang, Suren R. Sooranna, Danna Huang, Min Ou, Fei Xu, Lu Chen, Dan Huang
  Heliyon.2024; 10(14): e34297.     CrossRef
• Exploring Therapeutic Advances: A Comprehensive Review of Intestinal Microbiota Modulators
  Lara Pires, Ana M. González-Paramás, Sandrina A. Heleno, Ricardo C. Calhelha
  Antibiotics.2024; 13(8): 720.     CrossRef
• Polysaccharide-mediated modulation of gut microbiota in the treatment of liver diseases: Promising approach with significant challenges
  Yang Yang, Guifang Fan, Jianhang Lan, Xin Li, Xiaojiaoyang Li, Runping Liu
  International Journal of Biological Macromolecules.2024; 280: 135566.     CrossRef
• Network analysis and experimental verification of Salvia miltiorrhiza Bunge-Reynoutria japonica Houtt. drug pair in the treatment of non-alcoholic fatty liver disease
  Huafeng Chen, Shengzhe Yan, Qianru Xiang, Jiamin Liang, Xuejian Deng, Wanqin He, Yanzhen Cheng, Li Yang
  BMC Complementary Medicine and Therapies.2024;[Epub]     CrossRef
• Protective effects of Nogo-B deficiency in NAFLD mice and its multiomics analysis of gut microbiology and metabolism
  Xu Dong, Yu-Ting Xiong, Tingting He, Congyang Zheng, Junjie Li, Yingjie Zhuang, Yingjie Xu, Ye Xiu, Zhixin Wu, Xiaomei Zhao, Xiaohe Xiao, Zhaofang Bai, Lili Gao
  Genes & Nutrition.2024;[Epub]     CrossRef
• Polysaccharide of Atractylodes macrocephala Koidz alleviates NAFLD-induced hepatic inflammation in mice by modulating the TLR4/MyD88/NF-κB pathway
  Junyi Chen, Shuzhan Yang, Hanxia Luo, Xinliang Fu, Wanyan Li, Bingxin Li, Cheng Fu, Feiyue Chen, Danning Xu, Nan Cao
  International Immunopharmacology.2024; 141: 113014.     CrossRef
• Emerging mechanisms of non-alcoholic steatohepatitis and novel drug therapies
  Hao CHEN, Yang ZHOU, Haiping HAO, Jing XIONG
  Chinese Journal of Natural Medicines.2024; 22(8): 724.     CrossRef
• Therapeutic Role of Probiotics Against Environmental-Induced Hepatotoxicity: Mechanisms, Clinical Perspectives, Limitations, and Future
  Shehzeen Noor, Shaukat Ali, Muhammad Summer, Anfah Riaz, Laiba Nazakat, Aqsa
  Probiotics and Antimicrobial Proteins.2024;[Epub]     CrossRef
• Danshen polysaccharides alleviate AFB1 induced Jejunal injury
  Lu Zhang, Xincheng Gong, Shijia Zhang, Chanchan Cui, Qiongyi Zhang, Xiao Wang, Wanyu Shi, Yongzhan Bao
  Ecotoxicology and Environmental Safety.2024; 285: 117115.     CrossRef
• Edible fungi polysaccharides modulate gut microbiota and lipid metabolism: A review
  Huanyi Xu, Zhixiang Xue, Pengyi Wang, Quancen Lee, Zihui Chen, Bin Liu, Xiaoyan Liu, Feng Zeng
  International Journal of Biological Macromolecules.2024; 283: 137427.     CrossRef
• Modulation of efferocytosis and inflammation resolution by live and non-live probiotics through gut microbiota interactions in preclinical and clinical studies
  Mona Arianejad, Farnaz Tajeddini, Mina Zareardalan, Fatemeh Hosseinpour-Soleimani, Mohsen Sisakht, Amir Tajbakhsh, Mohammad-Taha Pirsalehi, Manica Negahdaripour
  Food Bioscience.2024; 62: 105498.     CrossRef
• Intestinal dysbiosis in nonalcoholic fatty liver disease (NAFLD): focusing on the gut–liver axis
  Hui Han, Yi Jiang, Mengyu Wang, Mebratu Melaku, Lei Liu, Yong Zhao, Nadia Everaert, Bao Yi, Hongfu Zhang
  Critical Reviews in Food Science and Nutrition.2023; 63(12): 1689.     CrossRef
• Epigenetic compounds targeting pharmacological target lysine specific demethylase 1 and its impact on immunotherapy, chemotherapy and radiotherapy for treatment of tumor recurrence and resistance
  Clement Agboyibor, Jianshu Dong, Clement Yaw Effah, Emmanuel Kwateng Drokow, Maxwell Ampomah-Wireko, Waqar Pervaiz, Augustina Sangmor, Xinli Ma, Jian Li, Hong-Min Liu, Peng Zhang
  Biomedicine & Pharmacotherapy.2023; 157: 113934.     CrossRef
• Salvia miltiorrhiza polysaccharides alleviate florfenicol-induced inflammation and oxidative stress in chick livers by regulating phagosome signaling pathway
  Xiao Wang, Wei Liu, Di Zhang, Yulan Jiao, Qianhui Zhao, Ying Liu, Wanyu Shi, Yongzhan Bao
  Ecotoxicology and Environmental Safety.2023; 249: 114428.     CrossRef
• Preparation methods, structural characteristics, and biological activity of polysaccharides from Salvia miltiorrhiza: A review
  Yuanyuan Li, Xin Zhang, Yining Li, Pei Yang, Zhiyuan Zhang, Hang Wu, Lihao Zhu, Yuhong Liu
  Journal of Ethnopharmacology.2023; 305: 116090.     CrossRef
• The spleen-strengthening and liver-draining herbal formula treatment of non-alcoholic fatty liver disease by regulation of intestinal flora in clinical trial
  Dengcheng Hui, Lu Liu, Nisma Lena Bahaji Azami, Jingru Song, Yanping Huang, Wan Xu, Chao Wu, Dong Xie, Yulang Jiang, Yanqin Bian, Mingyu Sun
  Frontiers in Endocrinology.2023;[Epub]     CrossRef
• The gut microbiota: A new perspective for tertiary prevention of hepatobiliary and gallbladder diseases
  Xiaoyu Huang, Yi Yang, Xueli Li, Xiaoya Zhu, Dan Lin, Yueran Ma, Min Zhou, Xiangyi Cui, Bingyu Zhang, Dongmei Dang, Yuhong Lü, Changwu Yue
  Frontiers in Nutrition.2023;[Epub]     CrossRef
• Polysaccharides from Ostrea rivularis rebuild the balance of gut microbiota to ameliorate non-alcoholic fatty liver disease in ApoE−/− mice
  Lijun Zhu, Mingmei Xiao, Jigang Luo, Shijie Li, Wenting Liu, Jinchuan Wu, Zhuoyue Song
  International Journal of Biological Macromolecules.2023; 235: 123853.     CrossRef
• Improvement of Inflammation, Diabetes, and Obesity by Forest Product-Derived Polysaccharides through the Human Intestinal Microbiota
  Seong-woo MYEONG, Yong Ju LEE, Do Hyun KIM, Tae-Jong KIM
  Journal of the Korean Wood Science and Technology.2023; 51(5): 358.     CrossRef
• Recent developments in Salvia miltiorrhiza polysaccharides: Isolation, purification, structural characteristics and biological activities
  Lei Luo, Juan Xue, Zheng Shao, Zhang Zhou, Wenqian Tang, Jinxin Liu, Hongfei Hu, Fan Yang
  Frontiers in Pharmacology.2023;[Epub]     CrossRef
• In Vitro Probiotic Properties of Bifidobacterium animalis subsp. lactis SF and Its Alleviating Effect on Non-Alcoholic Fatty Liver Disease
  Huihui Lv, Feiyue Tao, Lingling Peng, Shufang Chen, Zhongyue Ren, Jiahui Chen, Bo Yu, Hua Wei, Cuixiang Wan
  Nutrients.2023; 15(6): 1355.     CrossRef
• Ginsenoside Rg1 Ameliorates Pancreatic Injuries via the AMPK/mTOR Pathway in vivo and in vitro
  Jin Chen, Guoping Zhu, Wenbo Xiao, Xiaosong Huang, Kewu Wang, Yi Zong
  Diabetes, Metabolic Syndrome and Obesity.2023; Volume 16: 779.     CrossRef
• Managing metabolic diseases: The roles and therapeutic prospects of herb-derived polysaccharides
  Xinmei Xu, Lijie Wang, Kun Zhang, Yi Zhang, Gang Fan
  Biomedicine & Pharmacotherapy.2023; 161: 114538.     CrossRef
• Probio-X Relieves Symptoms of Hyperlipidemia by Regulating Patients’ Gut Microbiome, Blood Lipid Metabolism, and Lifestyle Habits
  Huan Wang, Cuicui Ma, Yan Li, Lei Zhang, lima A, Chengcong Yang, Feiyan Zhao, Haifeng Han, Dongyang Shang, Fan Yang, Yuying Zhang, Heping Zhang, Zhihong Sun, Ruifang Guo, Yuan Pin Hung
  Microbiology Spectrum.2023;[Epub]     CrossRef
• Sea cucumber sulfated polysaccharides and Lactobacillus gasseri synergistically ameliorate the overweight induced by altered gut microbiota in mice
  Zhengqi Liu, Chunqing Ai, Xinping Lin, Xiaoming Guo, Shuang Song, Beiwei Zhu
  Food & Function.2023; 14(9): 4106.     CrossRef
• Supplementation of Lactobacillus plantarum ATCC14917 mitigates non-alcoholic fatty liver disease in high-fat-diet-fed rats
  Xingjian Wen, Hejing Liu, Xiaoling Luo, Li Lui, Jiuyu Fan, Yajing Xing, Jia Wang, Xingfang Qiao, Na Li, Guixue Wang
  Frontiers in Microbiology.2023;[Epub]     CrossRef
• Potential herb–drug interactions between anti-COVID-19 drugs and traditional Chinese medicine
  Ling Ye, Shicheng Fan, Pengfei Zhao, Chenghua Wu, Menghua Liu, Shuang Hu, Peng Wang, Hongyu Wang, Huichang Bi
  Acta Pharmaceutica Sinica B.2023; 13(9): 3598.     CrossRef
• α‐Lactalbumin Peptide Asp‐Gln‐Trp Ameliorates Hepatic Steatosis and Oxidative Stress in Free Fatty Acids‐Treated HepG2 Cells and High‐Fat Diet‐Induced NAFLD Mice by Activating the PPARα Pathway
  Haoran Chen, Yanfeng Ma, Xiaofen Qi, Jianjun Tian, Ying Ma, Tianjiao Niu
  Molecular Nutrition & Food Research.2023;[Epub]     CrossRef
• Lonicerae flos polysaccharides improve nonalcoholic fatty liver disease by activating the adenosine 5′‐monophosphate‐activated protein kinase pathway and reshaping gut microbiota
  Chao Han, Zongshuo Li, Ruiying Liu, Zihan Zhao, Yu Wang, Xuli Zuo, Yushi Zhang, Zeyu Geng, Houyu Huang, Xiuzhen Pan, Weidong Li
  Journal of the Science of Food and Agriculture.2023; 103(15): 7721.     CrossRef
• Polysaccharides: The Potential Prebiotics for Metabolic Associated Fatty Liver Disease (MAFLD)
  Qin Guo, Yun Li, Xin Dai, Bangmao Wang, Jie Zhang, Hailong Cao
  Nutrients.2023; 15(17): 3722.     CrossRef
• Prebiotics and Probiotics: Therapeutic Tools for Nonalcoholic Fatty Liver Disease
  Alejandra Mijangos-Trejo, Natalia Nuño-Lambarri, Varenka Barbero-Becerra, Misael Uribe-Esquivel, Paulina Vidal-Cevallos, Norberto Chávez-Tapia
  International Journal of Molecular Sciences.2023; 24(19): 14918.     CrossRef
• Repair Effect and Mechanism of Electrospinning Nanocomposite Material with Gelatin-Bletilla Striata Gum/Salvia Miltiorrhiza on Orthopedic Refractory Wounds
  Geliang Hu, Ming Deng, Yonggang Ma, Jianghua Ming
  Journal of Biomedical Nanotechnology.2023; 19(10): 1783.     CrossRef
• Non-alcoholic fatty liver disease risk prediction model and health management strategies for older Chinese adults: a cross-sectional study
  Hong Pan, Baocheng Liu, Xin Luo, Xinxin Shen, Jijia Sun, An Zhang
  Lipids in Health and Disease.2023;[Epub]     CrossRef
• Modulatory effects of polysaccharides from plants, marine algae and edible mushrooms on gut microbiota and related health benefits: A review
  Henan Zhang, Fuchun Jiang, Jinsong Zhang, Wenhan Wang, Lin Li, Jingkun Yan
  International Journal of Biological Macromolecules.2022; 204: 169.     CrossRef
• Hepatoprotective mechanism of Silybum marianum on nonalcoholic fatty liver disease based on network pharmacology and experimental verification
  Guoyan Jiang, Chunhong Sun, Xiaodong Wang, Jie Mei, Chen Li, Honghong Zhan, Yixuan Liao, Yongjun Zhu, Jingxin Mao
  Bioengineered.2022; 13(3): 5216.     CrossRef
• Gut Microbiome in Non-Alcoholic Fatty Liver Disease: From Mechanisms to Therapeutic Role
  Haripriya Gupta, Byeong-Hyun Min, Raja Ganesan, Yoseph Asmelash Gebru, Satya Priya Sharma, Eunju Park, Sung-Min Won, Jin-Ju Jeong, Su-Been Lee, Min-Gi Cha, Goo-Hyun Kwon, Min-Kyo Jeong, Ji-Ye Hyun, Jung-A. Eom, Hee-Jin Park, Sang-Jun Yoon, Mi-Ran Choi, Do
  Biomedicines.2022; 10(3): 550.     CrossRef
• Efficacy and Safety of Probiotics Combined With Traditional Chinese Medicine for Ulcerative Colitis: A Systematic Review and Meta-Analysis
  Yu Hu, Zhen Ye, Yingqi She, Linzhen Li, Mingquan Wu, Kaihua Qin, Yuzheng Li, Haiqing He, Zhipeng Hu, Maoyi Yang, Fating Lu, Qiaobo Ye
  Frontiers in Pharmacology.2022;[Epub]     CrossRef
• Hepatoprotection of Probiotics Against Non-Alcoholic Fatty Liver Disease in vivo: A Systematic Review
  Faezah Sabirin, Siong Meng Lim, Chin Fen Neoh, Kalavathy Ramasamy
  Frontiers in Nutrition.2022;[Epub]     CrossRef
• Salvia miltiorrhiza Bge. (Danshen) in the Treating Non-alcoholic Fatty Liver Disease Based on the Regulator of Metabolic Targets
  Jie Liu, Yun Shi, Daiyin Peng, Lei Wang, Nianjun Yu, Guokai Wang, Weidong Chen
  Frontiers in Cardiovascular Medicine.2022;[Epub]     CrossRef
• The Regulatory Roles of Polysaccharides and Ferroptosis-Related Phytochemicals in Liver Diseases
  Yijing Ren, Siyue Li, Zixuan Song, Qiuping Luo, Yingying Zhang, Hao Wang
  Nutrients.2022; 14(11): 2303.     CrossRef
• Astaxanthin Alleviates Nonalcoholic Fatty Liver Disease by Regulating the Intestinal Flora and Targeting the AMPK/Nrf2 Signal Axis
  Yuhang Li, Juxiong Liu, Bojian Ye, Yueyao Cui, Ruiqi Geng, Shu Liu, Yufei Zhang, Wenjin Guo, Shoupeng Fu
  Journal of Agricultural and Food Chemistry.2022; 70(34): 10620.     CrossRef
• Application of metabolomics in the diagnosis of non-alcoholic fatty liver disease and the treatment of traditional Chinese medicine
  Mingmei Shao, Yifei Lu, Hongjiao Xiang, Junmin Wang, Guang Ji, Tao Wu
  Frontiers in Pharmacology.2022;[Epub]     CrossRef
• The chemistry and efficacy benefits of polysaccharides from Atractylodes macrocephala Koidz
  Congying Liu, Shengguang Wang, Zedong Xiang, Tong Xu, Mengyuan He, Qing Xue, Huaying Song, Peng Gao, Zhufeng Cong
  Frontiers in Pharmacology.2022;[Epub]     CrossRef
• An Ethnopharmaceutical Study on the Hypolipidemic Formulae in Taiwan Issued by Traditional Chinese Medicine Pharmacies
  Min-Han Chi, Jung Chao, Chien-Yu Ko, Shyh-Shyun Huang
  Frontiers in Pharmacology.2022;[Epub]     CrossRef
• Three water soluble polysaccharides with anti-inflammatory activities from Selaginella uncinata (Desv.) Spring
  Haochen Hui, Meng Gao, Xuerong Zhao, Lianhong Yin, Lina Xu, Lili Li, Jinyong Peng
  International Journal of Biological Macromolecules.2022; 222: 1983.     CrossRef
• Research Progress on the Therapeutic Effect of Polysaccharides on Non-Alcoholic Fatty Liver Disease through the Regulation of the Gut–Liver Axis
  Xiang Chen, Menghan Liu, Jun Tang, Ning Wang, Yibin Feng, Haotian Ma
  International Journal of Molecular Sciences.2022; 23(19): 11710.     CrossRef
• Modulation of gut microbiota by glycyrrhizic acid may contribute to its anti-NAFLD effect in rats fed a high-fat diet
  Sai Wang, Xin-Yu Li, Hong-Fang Ji, Liang Shen
  Life Sciences.2022; 310: 121110.     CrossRef
• Structural Alteration of Gut Microbiota During the Amelioration of Chronic Psychological Stress-Aggravated Diabetes-Associated Cognitive Decline by a Traditional Chinese Herbal Formula, ZiBu PiYin Recipe
  Wen Zhou, Libin Zhan, Huiying Xu, Lijing Zhang
  Journal of Alzheimer's Disease.2022; 90(4): 1465.     CrossRef
• Bacillus amyloliquefaciens SC06 in the diet improves egg quality of hens by altering intestinal microbiota and the effect is diminished by antimicrobial peptide
  Shujie Xu, Fei Wang, Peng Zou, Xiang Li, Qian Jin, Qi Wang, Baikui Wang, Yuanhao Zhou, Li Tang, Dongyou Yu, Weifen Li
  Frontiers in Nutrition.2022;[Epub]     CrossRef
• Effect of stigma maydis polysaccharide on the gut microbiota and transcriptome of VPA induced autism model rats
  Xiaolei Yang, Jiyuan Li, Yang Zhou, Ning Zhang, Jicheng Liu
  Frontiers in Microbiology.2022;[Epub]     CrossRef
• Salvia miltiorrhiza extract may exert an anti-obesity effect in rats with high-fat diet-induced obesity by modulating gut microbiome and lipid metabolism
  Zi-Li Ai, Xian Zhang, Wei Ge, You-Bao Zhong, Hai-Yan Wang, Zheng-Yun Zuo, Duan-Yong Liu
  World Journal of Gastroenterology.2022; 28(43): 6131.     CrossRef
• Dysregulated hepatic lipid metabolism and gut microbiota associated with early-stage NAFLD in ASPP2-deficiency mice
  Fang Xie, Hang-fei Xu, Jing Zhang, Xiao-ni Liu, Bu-xin Kou, Meng-yin Cai, Jing Wu, Jin-ling Dong, Qing-hua Meng, Yi Wang, Dexi Chen, Yang Zhang
  Frontiers in Immunology.2022;[Epub]     CrossRef
• Structural elucidation and anti-nonalcoholic fatty liver disease activity of Polygonatum cyrtonema Hua polysaccharide
  Wei Liu, Taili Shao, Lei Tian, Zhengrui Ren, Lan Gao, Zhiyan Tang, Zheng Fang, Pingchuan Yuan, Chunyan Liu, Jikun Li, Guodong Wang, Jun Han
  Food & Function.2022; 13(24): 12883.     CrossRef
• The protective effects of sulforaphane on high-fat diet-induced metabolic associated fatty liver disease in mice via mediating the FXR/LXRα pathway
  Shaotong Ma, Xinyi Pang, Shuhua Tian, Jing Sun, Qiaobin Hu, Xiangfei Li, Yingjian Lu
  Food & Function.2022; 13(24): 12966.     CrossRef
• Gut Microbiota is A Crucial Bridge Mediating the Pharmacological Effect of Labiatae Traditional Chinese Medicine
  Yanan Yang, Fang Zhang, Jiaqi Yu, Chongming Wu
  Diseases and Research.2022; 2(1): 13.     CrossRef
• Suppression of obesity and inflammation by polysaccharide from sporoderm-broken spore of Ganoderma lucidum via gut microbiota regulation
  Tingting Sang, Chengjie Guo, Dandan Guo, Jianjun Wu, Yujie Wang, Ying Wang, Jiajun Chen, Chaojie Chen, Kaikai Wu, Kun Na, Kang Li, Liu Fang, Cuiling Guo, Xingya Wang
  Carbohydrate Polymers.2021; 256: 117594.     CrossRef
• Annual review of LSD1/KDM1A inhibitors in 2020
  Dong-Jun Fu, Jun Li, Bin Yu
  European Journal of Medicinal Chemistry.2021; 214: 113254.     CrossRef
• Diet-Regulating Microbiota and Host Immune System in Liver Disease
  Jung A Eom, Goo Hyun Kwon, Na Yeon Kim, Eun Ju Park, Sung Min Won, Jin Ju Jeong, Ganesan Raja, Haripriya Gupta, Yoseph Asmelash Gebru, Satyapriya Sharma, Ye Rin Choi, Hyeong Seop Kim, Sang Jun Yoon, Ji Ye Hyun, Min Kyo Jeong, Hee Jin Park, Byeong Hyun Min
  International Journal of Molecular Sciences.2021; 22(12): 6326.     CrossRef
• Lactobacillus johnsonii BS15 combined with abdominal massage on intestinal permeability in rats with nonalcoholic fatty liver and cell biofilm repair
  Wei Zhang, Huanan Li, Na Zhao, Xiongfei Luo, Siwen Liu, an Bao, Yingying Chen, Haiteng Wang, Junshi Wang, Jingui Wang
  Bioengineered.2021; 12(1): 6354.     CrossRef
• Effects and Mechanisms of Probiotics, Prebiotics, Synbiotics, and Postbiotics on Metabolic Diseases Targeting Gut Microbiota: A Narrative Review
  Hang-Yu Li, Dan-Dan Zhou, Ren-You Gan, Si-Yu Huang, Cai-Ning Zhao, Ao Shang, Xiao-Yu Xu, Hua-Bin Li
  Nutrients.2021; 13(9): 3211.     CrossRef
• Correlation Analysis of Huayu Tongmai Decoction Intervention and Prognosis Indexes of Patients with Carotid Atherosclerosis
  Guangqing Cheng, Xiaoni Yan, Fengmeng Wang, Chao Chen, Muhammad Wasim Khan
  Evidence-Based Complementary and Alternative Medicine.2021; 2021: 1.     CrossRef
• Targeting the gut microbiota by Asian and Western dietary constituents: a new avenue for diabetes
  Abdul Rahman Conteh, Ruixue Huang
  Toxicology Research.2020; 9(4): 569.     CrossRef
• MiR-455 targeting SOCS3 improve liver lipid disorders in diabetic mice
  Shu Fang, Jie Feng, Hongbin Zhang, Ping Li, Yudan Zhang, Yanmei Zeng, Yingying Cai, Xiaochun Lin, Yaoming Xue, Meiping Guan
  Adipocyte.2020; 9(1): 179.     CrossRef
• Chinese Medicinal Herbs Targeting the Gut–Liver Axis and Adipose Tissue–Liver Axis for Non-Alcoholic Fatty Liver Disease Treatments: The Ancient Wisdom and Modern Science
  Shuwei Zhang, Yui-Tung Wong, Ka-Yu Tang, Hiu-Yee Kwan, Tao Su
  Frontiers in Endocrinology.2020;[Epub]     CrossRef
• Probiyotiklerin Kolon Mikrobiyotasına Etkileri: Güncel Çalışmalar
  Çağlar GÖKIRMAKLI, Zeynep SEYDİM
  Journal of Biotechnology and Strategic Health Research.2020; 4(3): 212.     CrossRef